Back to LXRX
Artal Group S.A. LXRX Position History
Lexicon Pharmaceuticals, Inc.
Quarters held
4
Latest value
$329.3M
Q3 2026
Peak value
$420.4M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $156.6M |
| Q1 2026 | $241.4M |
| Q2 2026 | $420.4M |
| Q3 2026 | $329.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $329.3M | 175.16M | — | — |
| Q2 2026 | $420.4M | 175.16M | — | — |
| Q1 2026 | $241.4M | 154.73M | — | — |
| Q4 2025 | $156.6M | 136.18M | — | — |
Other funds holding LXRX
$106.3M
$83.3M
$70.5M
$69.1M
$65.1M
$59.2M
$54.7M
$45.5M